This announcement is a separate document:
西藏卫信康医药股份有限公司关于子公司获得门冬氨酸钾镁注射液药品注册证书的公告
Announcement of Tibet Weixinkang Pharmaceutical obtaining the registration certificate for the medicine of Magnesia Aspartate Injection by its subsidiary.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated